Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > AI and Automation in Healthcare – 2026 Health IT Predictions

As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Pred...